Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.40 |
| ▸ | NPC1 | O15118 | 8/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | CASP3 | P42574 | 2/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.40 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.40 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13379339 | 0.90 | NPC1 (0.42) | RAB9ANPC1L3MBTL1CASP3SENP7 | |
| SCHEMBL13606269 | 0.87 | ALDH1A1 (0.44) | RAB9ANPC1L3MBTL1CASP3SENP7 | |
| SCHEMBL13606262 | 0.86 | NPC1 (0.48) | RAB9ANPC1L3MBTL1CASP3SENP7 | |
| SCHEMBL13379341 | 0.85 | HSP90AA1 (0.45) | RAB9ANPC1L3MBTL1CASP3SENP7 | |
| SCHEMBL13606267 | 0.85 | SMN1; SMN2 (0.41) | RAB9ANPC1L3MBTL1CASP3SENP7 | |
| SCHEMBL13606264 | 0.83 | MAPT (0.42) | RAB9ANPC1L3MBTL1CASP3SENP7 | |
| SCHEMBL13379337 | 0.83 | MAPT (0.46) | RAB9ANPC1L3MBTL1CASP3SENP7 | |
| SCHEMBL13379325 | 0.83 | MAPT (0.44) | RAB9ANPC1L3MBTL1CASP3SENP7 | |
| SCHEMBL13379334 | 0.82 | NPC1 (0.45) | RAB9ANPC1L3MBTL1CASP3SENP7 | |
| SCHEMBL20391191 | 0.82 | NR1H4 (0.43) | RAB9ANPC1L3MBTL1CASP3SENP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090286944-A1 | SELECT PHENOL-HETEROCYCLE LIGANDS, METAL COMPLEXES FORMED THEREFROM, AND THEIR USES AS CATALYSTS | SYMYX TECHNOLOGIES, INC. (US) | 2009-11-19 | — | — | US | disclosed |
| US-20090286944-A1 | SELECT PHENOL-HETEROCYCLE LIGANDS, METAL COMPLEXES FORMED THEREFROM, AND THEIR USES AS CATALYSTS | SYMYX TECHNOLOGIES, INC. (US) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286944-A1 | SELECT PHENOL-HETEROCYCLE LIGANDS, METAL COMPLEXES FORMED THEREFROM, AND THEIR USES AS CATALYSTS | WASF2, WEE1, CD40LG | RAB9A 4829/4885NPC1 4734/4885L3MBTL1 3390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.